TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Scanfarma AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
10,110
|
9,820
|
11,375 |
| Financial expenses |
6
|
1
|
1 |
| Earnings before taxes |
760
|
528
|
-177 |
| EBITDA |
728
|
526
|
-176 |
| Total assets |
7,613
|
7,567
|
7,348 |
| Current assets |
7,355
|
7,567
|
7,348 |
| Current liabilities |
890
|
1,378
|
1,392 |
| Equity capital |
4,665
|
3,905
|
3,582 |
| - share capital |
101
|
95
|
98 |
| Employees (average) |
5
|
6
|
7 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
61.3%
|
51.6%
|
48.7% |
| Turnover per employee |
2,022
|
1,637
|
1,625 |
| Profit as a percentage of turnover |
7.5%
|
5.4%
|
-1.6% |
| Return on assets (ROA) |
10.1%
|
7.0%
|
-2.4% |
| Current ratio |
826.4%
|
549.1%
|
527.9% |
| Return on equity (ROE) |
16.3%
|
13.5%
|
-4.9% |
| Change turnover |
-407
|
-1,213
|
-454 |
| Change turnover % |
-4%
|
-11%
|
-4% |
| Chg. No. of employees |
-1
|
-1
|
-1 |
| Chg. No. of employees % |
-17%
|
-14%
|
-13% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.